Connect with us

corporations

Cronos Group acquires CanAdelaar, the largest producer of adult-use cannabis in Europe, and enters the regulated market in the Netherlands.

Published

em

Reading Time: 2 minutes

Canadian cannabis producer Cronos Group has announced an agreement to acquire a full stake in CanAdelaar BV, the largest adult-use cannabis company operating under the regulated program in the Netherlands. The initial transaction value is €57,5 million ($67 million), with potential increases through additional payments dependent on the company's financial performance in 2026 and 2027.

CanAdelaar is one of ten licensed producers in the Wietexperiment, the pilot program that regulates the supply of cannabis to participating coffeeshops. The company operates a 50,000-square-meter greenhouse in Voorne aan Zee and is responsible for supplying virtually all 72 coffeeshops involved in the program.

The portfolio includes flowers, pre-rolled cigarettes, hashish, and edibles, positioning CanAdelaar as the only large-scale supplier within the Dutch model.

In financial terms, the company recorded revenues exceeding $47 million and an EBITDA of $28 million in the last twelve months, a significant increase compared to the results for 2024.

Cronos' European strategy

With this acquisition, Cronos reinforces its international expansion strategy, integrating its research in genetics and product development into a European market that, although limited in the number of municipalities covered, represents the only regulated program for cannabis for adult use in operation on the continent.

Em releaseThe company emphasizes that CanAdelaar offers an "immediate platform" to introduce its portfolio to the Dutch market, while establishing a solid presence in one of the countries with the longest tradition of regulated cannabis consumption and sale.

“The acquisition of CanAdelaar is a financially attractive and highly strategic transaction that will establish a strategic presence in Europe and allow us to leverage our investments in borderless products,” said Mike Gorenstein, President and CEO of Cronos, in a press release.

“The Netherlands has a long cannabis tradition, and its coffeeshops are world-renowned for playing a pivotal role in the evolution of the legal cannabis industry. European expansion is an important area of ​​focus for us, and we were particularly intrigued by the fact that the Netherlands legislated and established a responsible and efficient adult-use cannabis market with the Wietexperiment. We are excited to work with the Dutch government, regulatory bodies, coffeeshops, adult consumers, and all stakeholders to make the Wietexperiment a continued success. The CanAdelaar management team has expanded the business quickly and efficiently, making them market leaders in Europe’s largest adult-use cannabis market.”

Pending approvals and potential for expansion.

The completion of the purchase is expected in early 2026, pending regulatory approvals in the Netherlands. The future of the operation could be influenced by a possible decision by the Dutch government to expand the Wietexperiment to more municipalities, which would significantly increase the reach of the legal market.

If the program is expanded, or evolves into a national model, Cronos could benefit from a privileged position in a European market undergoing transformation.

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

More posts

With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. Winner of the Business of Cannabis Awards in the category "Journalist of the Year 2024", Laura was a correspondent for Jornal de Notícias in Rome, Italy, and Press Officer in the Office of the Minister of Education of the 21st Portuguese Government. She has an international certification in Permaculture (PDC) and created the street-art photography archive “Say What? Lisbon” @saywhatlisbon. Co-founder and Editor of CannaReporter® and coordinator of PTMC - Portugal Medical Cannabis, Laura directed the documentary “Pacientes” and was part of the steering group of the first Postgraduate Course in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.

Advertise with us!
Support independent journalism about cannabis.
Cannareporter needs you to continue informing.
If our work helps you stay up-to-date on cannabis policy, science, and industry, please consider supporting us with a monthly contribution on Patreon. Every contribution counts to keep the project free and independent.
Support us on Patreon
You can cancel your support at any time. Thank you for being part of our community.
Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertise with us!


Watch the Documentary "Patients" by Laura Ramos

Documentary Patients Laura Ramos help us grow

Mais recentes

National8 hours ago

Joana de Almeida Teixeira succeeds João Goulão as president of ICAD.

The Institute for Addictive Behaviors and Dependencies (ICAD) announced this week its new Board of Directors, which...

Cultivation12 hours ago

Czech Republic legalizes cultivation of up to 3 cannabis plants.

In the Czech Republic, adults over 21 can now cultivate up to 3 plants and possess up to 100 grams of...

Press Releases2 days ago

SOMAÍ and Lusófona University publish peer-reviewed study confirming method for batch consistency in full-spectrum cannabis oils.

SOMAÍ, a vertically integrated multinational operator (MCO) certified by EU-GMP, specializing in cannabinoid-based medicines, in...

Analysis6 days ago

Portugal has already spent more than 3 million euros on Epidyolex. Infarmed has been evaluating reimbursement for almost 4 years.

The Portuguese National Health Service (SNS) has already spent over 3 million euros on the drug Epidyolex...

Science7 days ago

The endocannabinoid system can signal latent psychoses and help prevent them. CBD may be a treatment option.

A systematic review published last month in the Journal of Psychopharmacology reveals that individuals at high risk of developing...

Hemp7 days ago

Ghana wants to implement the “highest taxes in the world” for hemp cultivation: $45,000 per hectare.

The community interested in growing hemp and cannabis in Ghana is contesting the new licensing regime proposed by...

Hemp1 weeks ago

South Africa: Limpopo reinforces its commitment to hemp with a pilot project led by local farmers.

The Limpopo province has made progress in consolidating its position in the emerging industrial hemp sector in South Africa,...

International1 weeks ago

Alexis Goosdeel ends 10-year term at EUDA: "Europe has not lost the battle"

Alexis Goosdeel, former executive director of the European Drug Administration (EUDA), has formally announced the end of his ten-year term...

Events1 weeks ago

Arquiconsult is hosting a webinar on validating ERP, AI, and Cloud systems in compliance with GxP on January 20th.

The increasing adoption of Artificial Intelligence (AI) and Cloud solutions is profoundly transforming highly regulated sectors, including...

Cultivation4 weeks ago

Italy: Council of State accepts appeal filed by hemp-related associations.

Italian hemp producers and traders celebrated another victory this week in their long legal battle against...